Evolved By Nature, the Boston-based company creating a proprietary library of Activated Silk molecules from natural silk protein, has secured $120 million in Series C financing to accelerate commercialisation,

The company’s full-scale production facility in Walpole, Massachusetts, opened in May 2022 and now produces 150 metric tons of Activated Silk per year – a 500% increase in capacity from 2021.

This financing supports full operation and the capacity to generate 900 metric tons of Activated Silk per year by 2024.

The company calculates this to equate to 900 million jars of petrochemical free skincare, 150 million square feet of biodegradable, polyurethane-free leather, sustainable finishing chemistry for 195 million pieces of performance apparel, or a replacement for 7,200 metric tons of non-biodegradable petrochemical surfactants.

Activated Silk molecules serve as renewably-sourced sustainable chemicals, bioactive ingredients and novel therapeutics for use in markets including apparel, personal care and medicine.

“We believe there is vast unlocked potential in utilising silk protein to produce innovative and sustainable products of a high quality,” said Olivia Steedman, executive managing director of key investor Teachers’ Venture Growth (TVG). “Evolved By Nature has a compelling vision to break through new scientific boundaries to reduce our reliance on problematic chemicals and build better, more sustainable supply chains in the process. We’re delighted to partner with them in executing this vision and growing their operations globally.”

“With TVG’s support, we can now reimagine new therapeutics and global supply chains that foster healthier relationships between industries and ecosystems, focusing first on skin treatments and high-performance coatings for leather and apparel,” added Greg Altman, CEO and co-founder of Evolved By Nature.

www.evolvedbynature.com